Regulatory expression of bone morphogenetic protein-6 system in aldosterone production by human adrenocortical cells

Regulatory Peptides

Volumn 138, Issue 2-3, 2007, Pages 133-140

  Inagaki, Kenichi ^a   Otsuka, Fumio ^a   Suzuki, Jiro ^a   Otani, Hiroyuki ^a   Takeda, Masaya ^a   Kano, Yoshihiro ^a   Miyoshi, Tomoko ^a   Yamashita, Misuzu ^a   Ogura, Toshio ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adrenal cortex; Aldosterone; Angiotensin II; Bone morphogenetic protein (BMP); Follistatin; H295R cell; Potassium (K)

Indexed keywords

ACTIVIN; ANGIOTENSIN II; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR; FOLLISTATIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM;

ADRENAL CORTEX CELL; ALDOSTERONE RELEASE; ARTICLE; AUTOCRINE EFFECT; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN SYNTHESIS; RNA TRANSLATION; UPREGULATION;

ADRENAL CORTEX; ALDOSTERONE; ANGIOTENSIN II; BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; FOLLISTATIN; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POTASSIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33845968516     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.08.014     Document Type: Article

References (25)

1. Foster R.H., MacFarlane C.H., and Bustamante M.O. Recent progress in understanding aldosterone secretion. Gen Pharmacol 28 (1997) 647-651
2. Lumbers E.R. Angiotensin and aldosterone. Regul Pept 80 (1999) 91-100
3. Ehrhart-Bornstein M., Hinson J.P., Bornstein S.R., Scherbaum W.A., and Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19 (1998) 101-143
4. Suzuki J., Otsuka F., Inagaki K., Takeda M., Ogura T., and Makino H. Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 145 (2004) 639-649
5. Otsuka F., Yao Z., Lee T.H., Yamamoto S., Erickson G.F., and Shimasaki S. Bone morphogenetic protein-15: identification of target cells and biological functions. J Biol Chem 275 (2000) 39523-39528
6. Shimasaki S., Moore R.K., Otsuka F., and Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25 (2004) 72-101
7. Otsuka F., Moore R.K., and Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 276 (2001) 32889-32895
8. Takeda M., Otsuka F., Suzuki J., Kishida M., Ogura T., Tamiya T., and Makino H. Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochem Biophys Res Commun 306 (2003) 812-818
9. Otsuka F., and Shimasaki S. A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 143 (2002) 4938-4941
10. Suzuki J., Otsuka F., Takeda M., Inagaki K., Miyoshi T., Mimura Y., Ogura T., Doihara H., and Makino H. Functional roles of the bone morphogenetic protein system in thyrotropin signaling in porcine thyroid cells. Biochem Biophys Res Commun 327 (2005) 1124-1130
11. Kano Y., Otsuka F., Takeda M., Suzuki J., Inagaki K., Miyoshi T., Miyamoto M., Otani H., Ogura T., and Makino H. Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells. Endocrinology 146 (2005) 5332-5340
12. DePaolo L.V., Bicsak T.A., Erickson G.F., Shimasaki S., and Ling N. Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198 (1991) 500-512
13. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., Sugino H., and Ueno N. Direct binding of follistatin to a complex of bone morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A 95 (1998) 9337-9342
14. Otsuka F., Moore R.K., Iemura S.-I., Ueno N., and Shimasaki S. Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 289 (2001) 961-966
15. Lin S.Y., Morrison J.R., Phillips D.J., and de Kretser D.M. Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 126 (2003) 133-148
16. Glister C., Kemp C.F., and Knight P.G. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127 (2004) 239-254
17. Inagaki K., Otsuka F., Suzuki J., Kano Y., Takeda M., Miyoshi T., Otani H., Mimura Y., Ogura T., and Makino H. Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells. Endocrinology 147 (2006) 2681-2689
18. Bird I.M., Hanley N.A., Word R.A., Mathis J.M., McCarthy J.L., Mason J.I., and Rainey W.E. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology 133 (1993) 1555-1561
19. Miyoshi T., Otsuka F., Suzuki J., Takeda M., Inagaki K., Kano Y., Otani H., Mimura Y., Ogura T., and Makino H. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Biol Reprod 74 (2006) 1073-1082
20. Nishiyama A., Yao L., Fan Y., Kyaw M., Kataoka N., Hashimoto K., Nagai Y., Nakamura E., Yoshizumi M., Shokoji T., Kimura S., Kiyomoto H., Tsujioka K., Kohno M., Tamaki T., Kajiya F., and Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 45 (2005) 710-716
21. Lesouhaitier O., Chiappe A., and Rossier M.F. Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression. Endocrinology 142 (2001) 4320-4330
22. Pradet-Balade B., Boulme F., Beug H., Mullner E.W., and Garcia-Sanz J.A. Translation control: bridging the gap between genomics and proteomics?. Trends Biochem Sci 26 (2001) 225-229
23. Clyne C.D., Zhang Y., Slutsker L., Mathis J.M., White P.C., and Rainey W.E. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 11 (1997) 638-649
24. Holland O.B., Mathis J.M., Bird I.M., and Rainey W.E. Angiotensin increases aldosterone synthase mRNA levels in human NCI-H295 cells. Mol Cell Endocrinol 94 (1993) R9-R13
25. Bird I.M., Mason J.I., and Rainey W.E. Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 134 (1994) 2468-2474